Target- |
MechanismStem cell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1/2 Intracavernous Injection of Umbilical Cord Stem Cells and Platelet-Rich Plasma for the Treatment of Erectile Dysfunction
A prospective clinical study to investigate the safety and efficacy of intracavernosal injections of umbilical cord stem cells (UCSCs) combined with platelet-rich plasma (PRP) for erectile dysfunction
100 Clinical Results associated with COR Clinic, Inc.
0 Patents (Medical) associated with COR Clinic, Inc.
100 Deals associated with COR Clinic, Inc.
100 Translational Medicine associated with COR Clinic, Inc.